Balakumar Chandrasekaran & Muthupandian Saravanan. (2023). Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics. Frontiers Media S.A..
Chicago Style (17th ed.) CitationBalakumar Chandrasekaran and Muthupandian Saravanan. Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationBalakumar Chandrasekaran and Muthupandian Saravanan. Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.